Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-12-20 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −2,948 $105.87 $312K 153,614
2019-11-12 FOEHR MATTHEW W President and COO Option exercise +1,001 $21.92 $22K 144,620
2019-11-12 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −1,001 68,827
2019-10-15 Boyce Sarah Director Grant or award +1,431 1,431
2019-10-15 Boyce Sarah Director Grant or award · Non-Qualified Stock Option (right to buy) +5,283 5,283
2019-09-19 HIGGINS JOHN L Chief Executive Officer Purchase · 0.75% Convertible Senior Notes due 2023 +0 $988,468.75 $0
2019-09-19 Korenberg Matthew E EVP,Finance & Strategy and CFO Purchase · 0.75% Convertible Senior Notes due 2023 +0 $989,937.50 $0
2019-09-19 HIGGINS JOHN L Chief Executive Officer Purchase · 0.75% Convertible Senior Notes due 2023 +0 $841,250.00 $0
2019-09-05 FOEHR MATTHEW W President and COO Option exercise +1,005 $21.92 $22K 143,619
2019-09-05 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −1,005 69,828
2019-09-03 Aryeh Jason Director Purchase +750 $87.01 $65K 67,203
2019-09-03 Korenberg Matthew E EVP,Finance & Strategy and CFO Purchase +500 $86.18 $43K 17,151
2019-08-12 FOEHR MATTHEW W President and COO Option exercise +1,163 $21.92 $25K 142,614
2019-08-12 FOEHR MATTHEW W President and COO Option exercise · Employee Stock Option (right to buy) −1,163 70,833
2019-08-05 Aryeh Jason Director Purchase +746 $90.01 $67K 66,453
2019-08-05 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise +669 $56.26 $38K 46,748
2019-08-05 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise +424 $85.79 $36K 47,172
2019-08-05 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise · Employee Stock Option (right to buy) −669 1,948
2019-08-05 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise · Employee Stock Option (right to buy) −424 4,153
2019-08-02 Davis Todd C Director Purchase +1,000 $93.59 $94K 49,474

Page 42 of 43 · 858 trades